US BANCORP \DE\ - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 113 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$2,000
-83.3%
336
-73.9%
0.00%
Q4 2021$12,000
-47.8%
1,2860.0%0.00%
Q3 2021$23,000
-28.1%
1,286
-3.3%
0.00%
Q2 2021$32,000
-5.9%
1,330
+3.4%
0.00%
Q1 2021$34,000
+240.0%
1,2860.0%0.00%
Q4 2020$10,000
+900.0%
1,286
+533.5%
0.00%
Q2 2020$1,0000.0%203
-22.5%
0.00%
Q1 2020$1,0002620.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders